MGS says Auto-injector Reimagined drug-delivery device, which harnesses its design and moldmaking capabilities, can help bring medicines to market faster.

Executives from Celldex Therapeutics (NASDAQ:CLDX) outlined a busy year of clinical and development milestones at the TD ...

Thank you, Lisa, and thanks for joining us. The biopharmaceutical and Diagnostic Solutions segment delivered another solid ...

Leerink Global Healthcare Conference 2026 March 10, 2026 10:40 AM EDTCompany ParticipantsBrian Lian - President, CEO ...

Xeris Biopharma benefits from the FDA's CRL to Corcept's relacorilant, removing a major competitive threat to Recorlev sales ...

UNAIDS officials in Pakistan say they are working with local pharmaceutical manufacturers to explore the possibility of ...

New South Carolina long snapper Emmet Rhoades plays football despite being a Type 1 diabetic. He talked about his diagnosis ...

Argenx delivered Q4 2025 product net sales of $1.3B and $4.2B for the full year, up 90% year over year as VYVGART demand accelerated globally. The company reported Q4 operating profit of $367M and ...

Eisai and Biogen have completed their rolling biologics license application in the US for a subcutaneous formulation of Alzheimer's disease therapy Leqembi previously delayed by the FDA on procedural ...

Lentinan is a bioactive polysaccharide extracted from shiitake mushrooms and renowned for its immunomodulatory effects. It is ...

Achieve accurate and calibration-free measurement of human serum albumin (HSA) molecular weight with BeSEC’s dual-angle light ...

Eli Lilly has launched new single-dose 2.5mg and 5.0mg vials of its obesity drug Zepbound in a move that it said would make it easier for people paying for the drug out-of-pocket to afford treatment.